Literature DB >> 18413382

Molecular and functional MRI of the tumor microenvironment.

Marie-France Penet1, Kristine Glunde, Michael A Jacobs, Arvind P Pathak, Zaver M Bhujwalla.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18413382      PMCID： PMC3075060          DOI： 10.2967/jnumed.107.043349

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  21 in total

1.  In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.

Authors:  Heike E Daldrup-Link; Reinhardt Meier; Martina Rudelius; Guido Piontek; Morand Piert; Stephan Metz; Marcus Settles; Christoph Uherek; Winfried Wels; Jürgen Schlegel; Ernst J Rummeny
Journal:  Eur Radiol       Date:  2004-12-23       Impact factor: 5.315

2.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.

Authors:  I Jolanda M de Vries; W Joost Lesterhuis; Jelle O Barentsz; Pauline Verdijk; J Han van Krieken; Otto C Boerman; Wim J G Oyen; Johannes J Bonenkamp; Jan B Boezeman; Gosse J Adema; Jeff W M Bulte; Tom W J Scheenen; Cornelis J A Punt; Arend Heerschap; Carl G Figdor
Journal:  Nat Biotechnol       Date:  2005-10-30       Impact factor: 54.908

3.  Monitoring T-lymphocyte trafficking in tumors undergoing immune rejection.

Authors:  De-En Hu; Mikko I Kettunen; Kevin M Brindle
Journal:  Magn Reson Med       Date:  2005-12       Impact factor: 4.668

4.  Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma.

Authors:  Liora Shiftan; Tomer Israely; Miriam Cohen; Veronica Frydman; Hagit Dafni; Robert Stern; Michal Neeman
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

5.  Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity.

Authors:  Galit Mazooz; Tevie Mehlman; Thung-Shen Lai; Charles S Greenberg; Mark W Dewhirst; Michal Neeman
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 7.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

9.  Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.

Authors:  Stasia A Anderson; John Glod; Ali S Arbab; Martha Noel; Parwana Ashari; Howard A Fine; Joseph A Frank
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

10.  Image-guided enzyme/prodrug cancer therapy.

Authors:  Cong Li; Marie-France Penet; Paul Winnard; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531
View more
  7 in total

Review 1.  Imaging the Tumor Microenvironment.

Authors:  Valerie S LeBleu
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

2.  Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.

Authors:  Yuehua Chen; Yuan Su; Xufeng Pang; Xiaoxia Song; Wanjun Zhao; Mingming Yu
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

Review 3.  Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer.

Authors:  Soo J Shin; Jaymes R Beech; Kimberly A Kelly
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

4.  Phototrophic purple bacteria as optoacoustic in vivo reporters of macrophage activity.

Authors:  Lena Peters; Ina Weidenfeld; Uwe Klemm; Anita Loeschcke; Robin Weihmann; Karl-Erich Jaeger; Thomas Drepper; Vasilis Ntziachristos; Andre C Stiel
Journal:  Nat Commun       Date:  2019-03-13       Impact factor: 14.919

5.  pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.

Authors:  MingMing Yu; YueHua Chen; ZhenGuang Wang; XiaoDong Ding
Journal:  Breast Cancer Res Treat       Date:  2020-02-07       Impact factor: 4.872

6.  An Experimental Study on [125I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.

Authors:  Mingming Yu; Yanqin Sun; Guangjie Yang; Zhenguang Wang
Journal:  Mol Imaging       Date:  2021-02-16       Impact factor: 4.488

7.  Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.

Authors:  George J Cerniglia; Nabendu Pore; Jeff H Tsai; Susan Schultz; Rosemarie Mick; Regine Choe; Xiaoman Xing; Turgut Durduran; Arjun G Yodh; Sydney M Evans; Cameron J Koch; Stephen M Hahn; Harry Quon; Chandra M Sehgal; William M F Lee; Amit Maity
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.